CytomX Therapeutics Inc Investor Event - Corporate Call Transcript
Well, good morning, good afternoon, everybody. I hope everybody can hear me okay. I'm Sean McCarthy, President, CEO and Chairman of CytomX Therapeutics. And it's a pleasure to have you here today for our investor event focused on conditionally activated therapeutics for the treatment of cancer.
We will, over the course of the next 2 hours, be making certain forward-looking statements, and I refer you to our safe harbor statements in our SEC filings.
So really it's a pleasure to be spending time with you all today as we take a deep dive into our science and our programs at CytomX. CytomX is a clinical stage oncology-focused organization, advancing a broad pipeline of candidate therapeutics for the treatment of a wide range of cancers. Our company has built around a unique and differentiated approach to localizing the activity of anticancer biologics to tumor tissue. We believe that localization of the activity of biologics presents an enormous opportunity.
The conditional activation technology that we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
